Back to search

Peptide record

TPDB03572

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
44 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03572
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF AFP-GFuse Antifp Antifungipept
standard
No
A 44-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
DVQCGEGHFCHDQTCCRASQGGACCPYSQGVCCADQRHCCPVGF
Physicochemical Analysis
C185H277N61O62S10
NILKMW
C
4668.21
5.73
5
4
9
-2
8.57
-0.243
26.59
Mammalian: 1.1 hour Yeast: 3 min E.coli: >10 hour
2115
45.31
19
Residue Composition
number
3
A
2
R
0
N
3
D
10
C
1
E
5
Q
6
G
3
H
0
I
0
L
0
K
0
M
2
F
2
P
2
S
1
T
0
W
1
Y
3
V
Amino Acid Distribution
A: 3 R: 2 N: 0 D: 3 C: 10 E: 1 Q: 5 G: 6 H: 3 I: 0 L: 0 K: 0 M: 0 F: 2 P: 2 S: 2 T: 1 W: 0 Y: 1 V: 3
Chemical Descriptors
44
C185H277N61O62S10
4668.21
5.73
-2
8.57
-0.243
Evidence Records 4 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
After 2 h incubation with 200 ug/ml peptide, log10 CFU reduction for S. zooepidemicus (>2.7 reduction by 99.8%), E. coli (0.88), P. aeruginosa (0.89, 87% reduction), K.pneumoniae (no change). Updated 7/2021
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
After 2 h incubation with 200 ug/ml peptide, log10 CFU reduction for S. zooepidemicus (>2.7 reduction by 99.8%), E. coli (0.88), P. aeruginosa (0.89, 87% reduction), K.pneumoniae (no change). Updated 7/2021
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

DRAMP

Other

After 2 h incubation with 200 ug/ml peptide, log10 CFU reduction for S. zooepidemicus (>2.7 reduction by 99.8%), E. coli (0.88), P. aeruginosa (0.89, 87% reduction), K.pneumoniae (no change). Updated 7/2021
Evidence 4 Activity

Activity

Antiviral

Source & Reference

DRAMP

Other

After 2 h incubation with 200 ug/ml peptide, log10 CFU reduction for S. zooepidemicus (>2.7 reduction by 99.8%), E. coli (0.88), P. aeruginosa (0.89, 87% reduction), K.pneumoniae (no change). Updated 7/2021